Intraperitoneal Glucose Tolerance Test (IPGTT) shows that GLP-1/<i>h</i>IgG2 improves glucose tolerance in CD-1 mice.

<p>After 16 h fasting, CD1 mice were i.p. injected with GLP-1/<i>h</i>IgG2 (1 µg/mouse). 30 min after the injection, IPGTT were conducted by i.p. injection of 1.5 g/kg of glucose and blood glucose levels were measured by a glucometer at 0, 10, 20, 30, 60 minutes after glucose administration. (B) 192-h after a single-dose injection of GLP-1/<i>h</i>IgG2 in CD1 mice, the mice were fasted for 16 h and IPGTT were conducted as described in (A).